Dr. Martin McLaughlin, Senior Genomic Services Manager at Almac Diagnostic Services, will lead the session on September 3, 2026. The discussion aims to bridge the gap between raw sample quality and actionable diagnostic data. McLaughlin plans to present real-world applications that help researchers maximize sequencing output, aiming to improve assay success rates in biomarker-driven clinical trials.

The presentation highlights why FFPE samples continue to represent both a critical resource and a significant technical challenge for integrated analysis. By examining these hurdles, the event provides a framework for labs to refine their preparation protocols and ensure more robust decision-making in high-stakes clinical environments. Registration is currently open for the session, scheduled for 11:00 am EDT.